Erratum: Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers (British Journal of Cancer (2009) 99 (1557-1563) DOI: 10.1038/sj.bjc.6604722));Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers

British Journal of Cancer

Volumn 99, Issue 10, 2008, Pages 1557-1563

  Maw, M K ^a   Fujimoto, J ^a   Tamaya, T ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; ID 1; Prognostic indicator; Tumour advancement; Uterine cervical cancer

Indexed keywords

INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER;

EID: 55949099888     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605205     Document Type: Erratum

References (47)

1. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K (1999) Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad USA 96: 9637-9641
2. Alani RM, Young AZ, Shifflett CB (2001) Id1 regulation of cellular senescence through transcriptional repression of p16/Ink2a. Proc Natl Acad Sci USA 98: 7812-7816
3. Bodner-Adler B, Nather A, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K (2006) Expression of Thrombospondin 1 (TSP-1) in patients with uterine smooth muscle tumors: An Immunohistochemical Study. Gynecol Oncol 103: 186-189
4. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
5. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J (1998) A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 18: 4577-4588
6. Folkman J (1985) Tumor angiogenesis. Adv Cancer Res 43: 175-203
7. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ, Desprez PY (2003) Id-1 as a molecular target in therapy for breast cancer invasion and metastasis. Proc Natl Acad Sci USA 100: 13543-13548
8. Fujimoto J, Aoki I, Toyoki H, Khatun S, Tamaya T (2002) Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. Ann Oncol 13: 1598-1604
9. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T (2000) The value of platelet-derived endothelial cell growth factor as a novel predictor of advancement of uterine cervical cancers. Cancer Res 60: 3662-3665
10. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T (1999a) Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Br J Cancer 80: 827-833
11. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T (1999b) The expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers. Br J Cancer 79: 1249-1254
12. Fujimoto J, Sakaguchi H, Hirose R, Wen H, Tamaya T (1999c) Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cervical cancers. Cancer Res 59: 3041-3044
13. Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter KC, Harris AL, Koukourakis MI (2001) The angiogenic 'vascular endothelial growth factor/flk-1 (KDR) receptor' pathway in patients with endometrial carcinoma. Cancer 92: 2569-2577
14. International Federation of Obstetrics and Gynecology (FIGO) News (1989) FIGO News. Int J Gynecol Obstet 28: 189-193
15. Jang KS, Han HX, Paik SS, Brown PH, Kong G (2006) Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Cancer Lett 244: 203-210
16. Langlands K, Down G.A, Kealey T (2000) Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res 60: 5929-5933
17. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A (2000) Id2 is a retinoblastoma protein target and mediates signaling by Myc oncoproteins. Nature 407: 592-598
18. Le Jossic K, Ilyin GP, Loyer P, Glaise D, Cariou S, Guguen-Guillouzo C (1994) Expression of helix-loop-helix factor Id-1 is dependent on the hepatocyte proliferation and differentiation status in rat liver and in primary culture. Cancer Res 54: 6065-6068
19. Lee KT, Lee YW, Lee JK, Chio SH, Rhee JC, Paik SS, Kong G (2004) Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancer. Br J Cancer 90: 1198-1203
20. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY (2000) A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60: 1332-1340
21. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC (2003) Id-1 expression promotes cell survival through activation of NF-kappaB signaling pathway in prostate cancer cells. Oncogene 22: 4498-4508
22. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201
23. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670-677
24. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y, Sowa M (1996) Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884-888
25. Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA, Korc M (1999) Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 155: 815-822
26. McCarty Jr KS, Miller LS, Cox EB, Konrath J, McCarty Sr KS (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109: 716-721
27. Norton JD (2000) ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905
28. Norton JD, Atherton GT (1998b) Coupling of cell growth control and apoptosis functions of Id proteins. Mol Cell Biol 18: 2371-2381
29. Norton JD, Deed RW, Craggs G, Sablitzky F (1998a) Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 8: 58-65
30. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067-1070
31. Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC (2002a) Over expression of ID-1 in prostate cancer. J Urol 167: 2598-2602
32. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW, Wong YC (2002b) Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis 23: 721-725
33. Polsky D, Young AZ, Busam KJ, Anani RM (2001) The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res 61: 6008-6011
34. Riechmann V, Sablitzky F (1995) Mutually exclusive expression of two dominant-negative helix-loop-helix (dnHLH) genes, Id4 and Id3, in the developing brain of the mouse suggests distinct regulatory roles of these dnHLH proteins during cellular proliferation and differentiation of the nervous system. Cell Growth Differ 6: 837-843
35. Riechmann V, van Cruchten I, Sablitzky F (1994) The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res 22: 749-755
36. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P (2001) Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 61: 5703-5706
37. Schindl M, Schoppmann SF, Strobel T, Heinzl H, Leisser C, Horvat R, Birner P (2003) Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumours. Clin Cancer Res 9: 779-785
38. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P (2003) Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer 104: 677-682
39. Singh J, Murata K, Itahana Y, Desprez PY (2002) Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene 21: 1812-1822
40. Straume O, Akslen LA (2005) Strong expression of ID-1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. Br J Cancer 93: 933-938
41. Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K, Alani RM (2002) Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2: 473-483
42. Wang X, Xu K, Ling MT, Wong YC, Feng HC, Nicholls J, Tsao SW (2002) Evidence of increased Id-1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells. Mol Carcinogen 35: 42-49
43. Wernert N, Okuducu AF, Pepper MS (2003) Ets-1 is expressed in capillary blood vessels but not in lymphatics. J Pathol 200: 561-567
44. Wu MP, Tzeng CC, Wu LW, Huang KF, Chou CY (2004) Thrombospondin 1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis. J Cancer 10(1): 27-32
45. Yan W, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y (1997) High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol 17: 7317-7327
46. Yates PR, Atherton GT, Deed RW, Norton JD, Sharrocks AD (1999) Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. EMBO J 18: 968-976
47. Zhang YW, Su Y, Volpert OV, Vande Woude GF (2003) Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 100(22): 12718-12723